# Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis

> **NCT05357352** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 263 (actual)

## Conditions studied

- Non-Alcoholic Fatty Liver Disease
- Non Alcoholic Steatohepatitis

## Interventions

- **OTHER:** NAFLD/NASH

## Key facts

- **NCT ID:** NCT05357352
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-24
- **Primary completion:** 2021-04-07
- **Final completion:** 2021-04-07
- **Target enrollment:** 263 (ACTUAL)
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05357352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05357352, "Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05357352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*